MedTrace Logo

Dexamethasone in Lower Third Molar Surgery

NCT02416869 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-04-22

No results posted yet for this study

Summary

The aim of this randomized double-blind cross over clinical trial is to investigate effectiveness of different routes of applications (intramuscular and submucous at the site of surgery) and doses (4 mg and 8 mg) of Dexamethasone on swelling, trismus, pain and quality of life after lower third molar surgery.

Conditions

  • Impacted Third Molar Tooth

Interventions

PROCEDURE

Intramuscular application

Patient receive 4mg of Dexamethasone by intramuscular application

PROCEDURE

Submucosal application

Patients receive 4mg of Dexamethasone by submucosal application

DRUG

4mg Dexamethasone submucosal

Patients receive 4mg of submucosal Dexamethasone

DRUG

8mg Dexamethasone submucosal

Patients receive 8mg of submucosal Dexamethasone

PROCEDURE

4mg Dexamethasone preoperative

Patients receive 4mg of Dexamethasone preoperatively

PROCEDURE

4mg Dexamethasone postoperative

Patients receive 4mg of Dexamethasone postoperatively

Sponsors & Collaborators

  • University of Belgrade

    lead OTHER

Principal Investigators

  • Miroslav M Andric, DDS, PhD · University of Zagreb

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2019-04-30
Completion
2019-04-30

Countries

  • Serbia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02416869 on ClinicalTrials.gov